Viremia in acute herpes zoster
A phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patien...
- Autores:
-
Satyaprakash, Anita K.
Tremaine, Anne Marie
Stelter, Arwen A.
Creed, Rosella
Ravanfar, Parisa
Mendoza, Natalia
Mehta, Satish K.
Rady, Peter L.
Pierson, Duane L.
Tyring, Stephen K.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2009
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/5149
- Acceso en línea:
- http://hdl.handle.net/20.500.12495/5149
https://doi.org/10.1086/599381
https://repositorio.unbosque.edu.co
- Palabra clave:
- Herpes zoster
Viremia
Infection
Microbiology
- Rights
- openAccess
- License
- Acceso abierto
id |
UNBOSQUE2_5540514d2249e1680b4bcaefeb78b901 |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/5149 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
spelling |
Satyaprakash, Anita K.Tremaine, Anne MarieStelter, Arwen A.Creed, RosellaRavanfar, ParisaMendoza, NataliaMehta, Satish K.Rady, Peter L.Pierson, Duane L.Tyring, Stephen K.2020-11-30T16:22:45Z2020-11-30T16:22:45Z20091537-6613http://hdl.handle.net/20.500.12495/5149https://doi.org/10.1086/599381instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengOxford University PressThe Journal of Infectious DiseasesThe Journal of Infectious Diseases, 1537-6613, Vol. 200, Nro. 1, 2009 p. 26-32https://academic.oup.com/jid/article/200/1/26/1746157Viremia in acute herpes zosterViremia in acute herpes zosterArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Herpes zosterViremiaInfectionMicrobiologyA phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patients began 7 days of valacyclovir treatment on day 3. Zoster lesion swab samples and samples of peripheral blood mononuclear cells were collected periodically throughout the study and were analyzed for varicella-zoster virus (VZV) DNA by use of both qualitative and real-time polymerase chain reaction. Serum samples collected periodically throughout the study were analyzed for VZV DNA by use of real-time polymerase chain reaction. VZV DNA was detected in all 3 sample types, and the number of viral copies correlated with the progression of herpes zoster. No statistically significant differences were seen between the placebo- and sorivudine-treated groups with respect to clinical characteristics or laboratory test results. The detection of VZV DNA in the serum and peripheral blood mononuclear cells of all 25 zoster patients documents that viremia is a common manifestation of herpes zoster. Sorivudine cream appears to be a safe and well-tolerated adjuvant therapy; however, further phase 2 studies are needed to determine its clinical efficacy for the treatment of herpes zoster. Trials registration. ClinicalTrials.gov identifier: NCT00652184.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2009-07ORIGINALSatyaprakash_Anita_K_2009.pdfSatyaprakash_Anita_K_2009.pdfapplication/pdf657762https://repositorio.unbosque.edu.co/bitstreams/ffc4340e-d025-4189-916f-839952b6605d/download2ead7a8b81530bd6a0555dbcf0daf4f6MD51THUMBNAILSatyaprakash_Anita_K_2009.pdf.jpgSatyaprakash_Anita_K_2009.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/6bc42d61-bb6c-403f-849e-6299a6c06ddd/download7210a811635d1799e7c05fee5d259be7MD52TEXTSatyaprakash_Anita_K_2009.pdf.txtSatyaprakash_Anita_K_2009.pdf.txtExtracted texttext/plain31605https://repositorio.unbosque.edu.co/bitstreams/fc64ec83-d44c-4f30-aebb-7bf939133fe2/download75914ffbe582345b145e05513e561708MD5320.500.12495/5149oai:repositorio.unbosque.edu.co:20.500.12495/51492024-02-07 11:40:40.823restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.com |
dc.title.spa.fl_str_mv |
Viremia in acute herpes zoster |
dc.title.translated.spa.fl_str_mv |
Viremia in acute herpes zoster |
title |
Viremia in acute herpes zoster |
spellingShingle |
Viremia in acute herpes zoster Herpes zoster Viremia Infection Microbiology |
title_short |
Viremia in acute herpes zoster |
title_full |
Viremia in acute herpes zoster |
title_fullStr |
Viremia in acute herpes zoster |
title_full_unstemmed |
Viremia in acute herpes zoster |
title_sort |
Viremia in acute herpes zoster |
dc.creator.fl_str_mv |
Satyaprakash, Anita K. Tremaine, Anne Marie Stelter, Arwen A. Creed, Rosella Ravanfar, Parisa Mendoza, Natalia Mehta, Satish K. Rady, Peter L. Pierson, Duane L. Tyring, Stephen K. |
dc.contributor.author.none.fl_str_mv |
Satyaprakash, Anita K. Tremaine, Anne Marie Stelter, Arwen A. Creed, Rosella Ravanfar, Parisa Mendoza, Natalia Mehta, Satish K. Rady, Peter L. Pierson, Duane L. Tyring, Stephen K. |
dc.subject.keywords.spa.fl_str_mv |
Herpes zoster Viremia Infection Microbiology |
topic |
Herpes zoster Viremia Infection Microbiology |
description |
A phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster. In this randomized, placebo-controlled, double-blind trial, 25 patients were treated with either sorivudine or placebo cream. All patients began 7 days of valacyclovir treatment on day 3. Zoster lesion swab samples and samples of peripheral blood mononuclear cells were collected periodically throughout the study and were analyzed for varicella-zoster virus (VZV) DNA by use of both qualitative and real-time polymerase chain reaction. Serum samples collected periodically throughout the study were analyzed for VZV DNA by use of real-time polymerase chain reaction. VZV DNA was detected in all 3 sample types, and the number of viral copies correlated with the progression of herpes zoster. No statistically significant differences were seen between the placebo- and sorivudine-treated groups with respect to clinical characteristics or laboratory test results. The detection of VZV DNA in the serum and peripheral blood mononuclear cells of all 25 zoster patients documents that viremia is a common manifestation of herpes zoster. Sorivudine cream appears to be a safe and well-tolerated adjuvant therapy; however, further phase 2 studies are needed to determine its clinical efficacy for the treatment of herpes zoster. Trials registration. ClinicalTrials.gov identifier: NCT00652184. |
publishDate |
2009 |
dc.date.issued.none.fl_str_mv |
2009 |
dc.date.accessioned.none.fl_str_mv |
2020-11-30T16:22:45Z |
dc.date.available.none.fl_str_mv |
2020-11-30T16:22:45Z |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.local.none.fl_str_mv |
Artículo de revista |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
http://purl.org/coar/resource_type/c_6501 |
dc.identifier.issn.none.fl_str_mv |
1537-6613 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/5149 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1086/599381 |
dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
https://repositorio.unbosque.edu.co |
identifier_str_mv |
1537-6613 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque |
url |
http://hdl.handle.net/20.500.12495/5149 https://doi.org/10.1086/599381 https://repositorio.unbosque.edu.co |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.spa.fl_str_mv |
The Journal of Infectious Diseases, 1537-6613, Vol. 200, Nro. 1, 2009 p. 26-32 |
dc.relation.uri.none.fl_str_mv |
https://academic.oup.com/jid/article/200/1/26/1746157 |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
dc.rights.creativecommons.none.fl_str_mv |
2009-07 |
rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2009-07 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Oxford University Press |
dc.publisher.journal.spa.fl_str_mv |
The Journal of Infectious Diseases |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/ffc4340e-d025-4189-916f-839952b6605d/download https://repositorio.unbosque.edu.co/bitstreams/6bc42d61-bb6c-403f-849e-6299a6c06ddd/download https://repositorio.unbosque.edu.co/bitstreams/fc64ec83-d44c-4f30-aebb-7bf939133fe2/download |
bitstream.checksum.fl_str_mv |
2ead7a8b81530bd6a0555dbcf0daf4f6 7210a811635d1799e7c05fee5d259be7 75914ffbe582345b145e05513e561708 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1814100834067152896 |